Search

Search Constraints

You searched for: Author/Creator Kennedy, Lisa

Search Results

2. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy. (3rd August 2019)

3. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America. (4th May 2018)

4. Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. (2nd January 2020)

7. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers. (September 2021)